| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
35,980 |
29,746 |
$2.55M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,033 |
14,278 |
$769K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,400 |
4,341 |
$311K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,981 |
2,860 |
$233K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,826 |
2,787 |
$201K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,414 |
7,199 |
$198K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,415 |
2,349 |
$162K |
| 92567 |
|
11,089 |
9,968 |
$70K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
408 |
380 |
$25K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
121 |
12 |
$24K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
316 |
294 |
$23K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,682 |
1,651 |
$23K |
| 99401 |
|
977 |
816 |
$22K |
| 54450 |
|
275 |
264 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
812 |
718 |
$15K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
445 |
437 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
100 |
96 |
$9K |
| 81002 |
|
2,851 |
2,469 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
821 |
640 |
$8K |
| 99173 |
|
11,510 |
10,173 |
$7K |
| 99385 |
|
81 |
77 |
$7K |
| 99381 |
|
89 |
86 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
313 |
303 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
356 |
321 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
1,657 |
1,475 |
$4K |
| 99188 |
|
291 |
280 |
$4K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
34 |
34 |
$3K |
| 99382 |
|
30 |
30 |
$2K |
| 99383 |
|
27 |
26 |
$2K |
| 69210 |
|
50 |
45 |
$1K |
| 90686 |
|
3,026 |
2,333 |
$1K |
| 99384 |
|
12 |
12 |
$1K |
| 96160 |
|
323 |
314 |
$994.52 |
| 99000 |
|
1,404 |
1,069 |
$756.37 |
| 99460 |
|
14 |
14 |
$736.35 |
| 96127 |
|
583 |
392 |
$672.25 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
21 |
21 |
$633.91 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
14 |
14 |
$624.93 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
420 |
366 |
$603.02 |
| 90651 |
|
1,112 |
984 |
$561.88 |
| 90670 |
|
1,970 |
1,793 |
$450.87 |
| 94664 |
|
30 |
29 |
$416.91 |
| 87632 |
|
22 |
17 |
$239.51 |
| A4617 |
Mouth piece |
482 |
333 |
$222.11 |
| 80061 |
Lipid panel |
41 |
36 |
$208.56 |
| 93000 |
|
12 |
12 |
$189.23 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
21 |
16 |
$187.76 |
| 90474 |
|
13 |
12 |
$165.13 |
| 90698 |
|
1,228 |
1,133 |
$163.31 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
24 |
19 |
$156.35 |
| 36416 |
|
289 |
224 |
$142.23 |
| 90744 |
|
648 |
600 |
$130.99 |
| 86580 |
|
15 |
15 |
$95.72 |
| 83655 |
|
15 |
13 |
$95.22 |
| 90715 |
|
272 |
256 |
$61.81 |
| 90696 |
|
117 |
116 |
$46.95 |
| 90710 |
|
198 |
196 |
$46.95 |
| 94760 |
|
1,088 |
838 |
$46.82 |
| 87486 |
|
22 |
17 |
$39.38 |
| 87541 |
|
22 |
17 |
$39.38 |
| 87581 |
|
22 |
17 |
$39.38 |
| 90658 |
|
136 |
123 |
$36.48 |
| 81025 |
|
24 |
12 |
$36.40 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
16 |
12 |
$32.70 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
263 |
226 |
$28.31 |
| 90756 |
|
123 |
123 |
$18.91 |
| 90633 |
|
651 |
597 |
$15.58 |
| 90680 |
|
760 |
705 |
$13.91 |
| A4616 |
Tubing (oxygen), per foot |
451 |
317 |
$7.41 |
| 81001 |
|
20 |
18 |
$3.54 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
231 |
193 |
$3.01 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
12 |
$1.40 |
| 3008F |
|
204 |
143 |
$0.00 |
| 90716 |
|
94 |
93 |
$0.00 |
| 90620 |
|
49 |
39 |
$0.00 |
| 87640 |
|
21 |
16 |
$0.00 |
| 87498 |
|
21 |
16 |
$0.00 |
| 90656 |
|
66 |
63 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
36 |
18 |
$0.00 |
| 90647 |
|
13 |
13 |
$0.00 |
| 3074F |
|
40 |
31 |
$0.00 |
| 3051F |
|
14 |
12 |
$0.00 |
| 90734 |
|
766 |
697 |
$0.00 |
| 1160F |
|
94 |
73 |
$0.00 |
| 90685 |
|
183 |
179 |
$0.00 |
| 90621 |
|
12 |
12 |
$0.00 |
| 90707 |
|
78 |
77 |
$0.00 |
| 90700 |
|
41 |
40 |
$0.00 |
| 87641 |
|
21 |
16 |
$0.00 |
| 87799 |
|
21 |
16 |
$0.00 |
| 87634 |
|
21 |
16 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
21 |
16 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
24 |
12 |
$0.00 |